Table 3. Effects of different treatments on oxidative activity in male rats.
Groups |
parameters (Mean ± S.D.) |
|
MDA (nmol/ml) |
GHPx (Pg /ml) |
|
Control |
5.9 ± 0.36c |
119.5 ± 6.81a |
Lead acetate (U/L) |
8.2 ± 0.47a |
83.9 ± 5.29d |
Lead + L.Carnitin (U/L) |
7.2 ± 0.40b |
103.0 ± 5.88c |
Lead + L.Carnitin Nano (U/L) |
6.9 ± 0.56b |
111.7 ± 4.36b |
L.Carnitin (U/L) |
5.7 ± 1.15c |
123.8 ± 4.99a |
L.Carnitin Nano (U/L) |
5.3 ± 0.52c |
124.1 ± 4.29a |
LSD |
0.57 |
4.79 |
*The different small letters do not show significant differences at (P<0.05.), a, b, c, d, and e letters refer to significance between the groups according to the Duncan test. |